{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:37:19Z","timestamp":1761323839439,"version":"3.40.3"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s00482-012-1221-x","type":"journal-article","created":{"date-parts":[[2012,9,12]],"date-time":"2012-09-12T00:52:05Z","timestamp":1347411125000},"page":"523-536","source":"Crossref","is-referenced-by-count":23,"title":["Antidepressiva zur Behandlung der Depression bei Palliativpatienten","Antidepressants for treatment of depression in palliative patients"],"prefix":"10.1007","volume":"26","author":[{"given":"M.","family":"Ujeyl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"M\u00fcller-Oerlinghausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,14]]},"reference":[{"key":"1221_CR1","first-page":"CD007503","volume":"Rev","author":"Rayner","year":"2010","unstructured":"Rayner L, Price A, Evans A et al (2010) Antidepressants for depression in physically ill people. Cochrane Database Syst Rev (3):CD007503","journal-title":"Cochrane Database Syst"},{"key":"1221_CR2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/0269216310380764","volume":"25","author":"Rayner","year":"2011","unstructured":"Rayner L, Price A, Evans A et al (2011) Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis. Palliat Med 25:36\u201351","journal-title":"Palliat Med"},{"key":"1221_CR3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/sj.bjc.6602949","volume":"94","author":"Williams","year":"2006","unstructured":"Williams S, Dale J (2006) The effectiveness of treatment for depression\/depressive symptoms in adults with cancer: a systematic review. Br J Cancer 94:372\u2013390","journal-title":"Br J Cancer"},{"key":"1221_CR4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00520-006-0145-3","volume":"15","author":"Rodin","year":"2007","unstructured":"Rodin G, Lloyd N, Katz M et al (2007) The treatment of depression in cancer patients: a systematic review. Support Care Cancer 15:123\u2013136","journal-title":"Support Care Cancer"},{"key":"1221_CR5","first-page":"CD006932","volume":"Rev","author":"Rooney","year":"2010","unstructured":"Rooney A, Grant R (2010) Pharmacological treatment of depression in patients with a primary brain tumour. Cochrane Database Syst Rev (3):CD006932","journal-title":"Cochrane Database Syst"},{"key":"1221_CR6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/apc.2005.19.813","volume":"19","author":"Himelhoch","year":"2005","unstructured":"Himelhoch S, Medoff DR (2005) Efficacy of antidepressant medication among HIV-positive individuals with depression: a systematic review and meta-analysis. AIDS Patient Care STDS 19:813\u2013822","journal-title":"AIDS Patient Care STDS"},{"key":"1221_CR7","first-page":"CD007295","volume":"Rev","author":"Koch","year":"2011","unstructured":"Koch MW, Glazenborg A, Uyttenboogaart M et al (2011) Pharmacologic treatment of depression in multiple sclerosis. Cochrane Database Syst Rev (2):CD007295","journal-title":"Cochrane Database Syst"},{"key":"1221_CR8","first-page":"CD003465","volume":"Rev","author":"Ghazi-Noori","year":"2003","unstructured":"Ghazi-Noori S, Chung TH, Deane K et al (2003) Therapies for depression in Parkinson\u2019s disease. Cochrane Database Syst Rev (2):CD003465","journal-title":"Cochrane Database Syst"},{"key":"1221_CR9","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/mds.20555","volume":"20","author":"Weintraub","year":"2005","unstructured":"Weintraub D, Morales KH, Moberg PJ et al (2005) Antidepressant studies in Parkinson\u2019s disease: a review and meta-analysis. Mov Disord 20:1161\u20131169","journal-title":"Mov Disord"},{"key":"1221_CR10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2377-10-49","volume":"10","author":"Skapinakis","year":"2010","unstructured":"Skapinakis P, Bakola E, Salanti G et al (2010) Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson\u2019s disease: a systematic review and meta-analysis of randomized controlled trials. BMC Neurol 10:49","journal-title":"BMC Neurol"},{"key":"1221_CR11","first-page":"CD003944","volume":"Rev","author":"Bains","year":"2005","unstructured":"Bains J, Birks JS, Dening TR (2005) The efficacy of antidepressants in the treatment of depression in dementia. Cochrane Database Syst Rev (4):CD003944","journal-title":"Cochrane Database Syst"},{"key":"1221_CR12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1532-5415.2011.03355.x","volume":"59","author":"Nelson","year":"2011","unstructured":"Nelson JC, Devanand DP (2011) A systematic review and meta-analysis of placebo-controlled antidepressant studies in people with depression and dementia: [See Editorial Comments by Eric J. Lenze, MD on pp 0000\u20130000]. J Am Geriatr Soc 59:577\u2013585","journal-title":"J Am Geriatr Soc"},{"key":"1221_CR13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/SPC.0b013e328325d17a","volume":"3","author":"Price","year":"2009","unstructured":"Price A, Hotopf M (2009) The treatment of depression in patients with advanced cancer undergoing palliative care. Curr Opin Support Palliat Care 3:61\u201366","journal-title":"Curr Opin Support Palliat Care"},{"key":"1221_CR14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/030006059902700502","volume":"27","author":"De","year":"1999","unstructured":"De Wit S, Cremers L, Hirsch D et al (1999) Efficacy and safety of trazodone versus clorazepate in the treatment of HIV-positive subjects with adjustment disorders: a pilot study. J Int Med Res 27:223\u2013232","journal-title":"J Int Med Res"},{"key":"1221_CR15","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1037\/0022-006X.69.6.942","volume":"69","author":"Mohr","year":"2001","unstructured":"Mohr DC, Boudewyn AC, Goodkin DE et al (2001) Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol 69:942\u2013949","journal-title":"J Consult Clin Psychol"},{"key":"1221_CR16","first-page":"CD005537","volume":"Rev","author":"Akechi","year":"2008","unstructured":"Akechi T, Okuyama T, Onishi J et al (2008) Psychotherapy for depression among incurable cancer patients. Cochrane Database Syst Rev (2):CD005537","journal-title":"Cochrane Database Syst"},{"key":"1221_CR17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-0031-1279760","volume":"21","author":"Baumgart","year":"2011","unstructured":"Baumgart S, M\u00fcller-Oerlinghausen B, Schenderea CFG (2011) Wirksamkeit der Massagetherapie bei Depression und Angsterkrankungen sowie bei Depressivit\u00e4t und Angst als Komorbidit\u00e4t \u2013 Eine systematische \u00dcbersicht kontrollierter Studien. Phys Med Rehab Kuror 21:167\u2013182","journal-title":"Phys Med Rehab Kuror"},{"key":"1221_CR18","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/sj.bjc.6602103","volume":"91","author":"Uitterhoeve","year":"2004","unstructured":"Uitterhoeve RJ, Vernooy M, Litjens M et al (2004) Psychosocial interventions for patients with advanced cancer\u2014a systematic review of the literature. Br J Cancer 91:1050\u20131062","journal-title":"Br J Cancer"},{"key":"1221_CR19","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700","journal-title":"BMJ"},{"key":"1221_CR20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/01.jcp.0000088908.24613.db","volume":"23","author":"Avila","year":"2003","unstructured":"Avila A, Cardona X, Martin-Baranera M et al (2003) Does nefazodone improve both depression and Parkinson disease? A pilot randomized trial. J Clin Psychopharmacol 23:509\u2013513","journal-title":"J Clin Psychopharmacol"},{"key":"1221_CR21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(11)60830-1","volume":"378","author":"Banerjee","year":"2011","unstructured":"Banerjee S, Hellier J, Dewey M et al (2011) Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet 378:403\u2013411","journal-title":"Lancet"},{"key":"1221_CR22","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/mds.21966","volume":"23","author":"Devos","year":"2008","unstructured":"Devos D, Dujardin K, Poirot I et al (2008) Comparison of desipramine and citalopram treatments for depression in Parkinson\u2019s disease: a double-blind, randomized, placebo-controlled study. Mov Disord 23:850\u2013857","journal-title":"Mov Disord"},{"key":"1221_CR23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.genhosppsych.2007.08.002","volume":"30","author":"Ehde","year":"2008","unstructured":"Ehde DM, Kraft GH, Chwastiak L et al (2008) Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis. Gen Hosp Psychiatry 30:40\u201348","journal-title":"Gen Hosp Psychiatry"},{"key":"1221_CR24","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/gps.865","volume":"18","author":"Leentjens","year":"2003","unstructured":"Leentjens AF, Vreeling FW, Luijckx GJ, Verhey FR (2003) SSRIs in the treatment of depression in Parkinson\u2019s disease. Int J Geriatr Psychiatry 18:552\u2013554","journal-title":"Int J Geriatr Psychiatry"},{"key":"1221_CR25","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archpsyc.60.7.737","volume":"60","author":"Lyketsos","year":"2003","unstructured":"Lyketsos CG, DelCampo L, Steinberg M et al (2003) Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Arch Gen Psychiatry 60:737\u2013746","journal-title":"Arch Gen Psychiatry"},{"key":"1221_CR26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00019442-200002000-00009","volume":"8","author":"Magai","year":"2000","unstructured":"Magai C, Kennedy G, Cohen CI, Gomberg D (2000) A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer\u2019s disease. Am J Geriatr Psychiatry 8:66\u201374","journal-title":"Am J Geriatr Psychiatry"},{"key":"1221_CR27","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1212\/01.wnl.0000336340.89821.b3","volume":"72","author":"Menza","year":"2009","unstructured":"Menza M, Dobkin RD, Marin H et al (2009) A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology 72:886\u2013892","journal-title":"Neurology"},{"key":"1221_CR28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1017\/S104161020100761X","volume":"13","author":"Petracca","year":"2001","unstructured":"Petracca GM, Chemerinski E, Starkstein SE (2001) A double-blind, placebo-controlled study of fluoxetine in depressed patients with Alzheimer\u2019s disease. Int Psychogeriatr 13:233\u2013240","journal-title":"Int Psychogeriatr"},{"key":"1221_CR29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/JGP.0b013e3181cc0333","volume":"18","author":"Weintraub","year":"2010","unstructured":"Weintraub D, Rosenberg PB, Drye LT et al (2010) Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes. Am J Geriatr Psychiatry 18:332\u2013340","journal-title":"Am J Geriatr Psychiatry"},{"key":"1221_CR30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/08039489850149741","volume":"52","author":"Wermuth","year":"1998","unstructured":"Wermuth L, S\u00f6rensen PS, Timm S et al (1998) Depression in idiopathic Parkinson\u2019s disease treated with citalopram, a placebo-controlled trial. Nord J Psychiatry 52:163\u2013169","journal-title":"Nord J Psychiatry"},{"key":"1221_CR31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/JGP.0b013e3181c796eb","volume":"18","author":"Rosenberg","year":"2010","unstructured":"Rosenberg PB, Drye LT, Martin BK et al (2010) Sertraline for the treatment of depression in Alzheimer disease. Am J Geriatr Psychiatry 18:136\u2013145","journal-title":"Am J Geriatr Psychiatry"},{"key":"1221_CR32","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/WNL.0b013e3181ebdd79","volume":"75","author":"Weintraub","year":"2010","unstructured":"Weintraub D, Mavandadi S, Mamikonyan E et al (2010) Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease. Neurology 75:448\u2013455","journal-title":"Neurology"},{"key":"1221_CR33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1176\/ajp.155.3.367","volume":"155","author":"Elliott","year":"1998","unstructured":"Elliott AJ, Uldall KK, Bergam K et al (1998) Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients. Am J Psychiatry 155:367\u2013372","journal-title":"Am J Psychiatry"},{"key":"1221_CR34","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1200\/JCO.2003.08.025","volume":"21","author":"Fisch","year":"2003","unstructured":"Fisch MJ, Loehrer PJ, Kristeller J et al (2003) Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group. J Clin Oncol 21:1937\u20131943","journal-title":"J Clin Oncol"},{"key":"1221_CR35","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ahj.2007.02.024","volume":"153","author":"Gottlieb","year":"2007","unstructured":"Gottlieb SS, Kop WJ, Thomas SA et al (2007) A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure. Am Heart J 153:868\u2013873","journal-title":"Am Heart J"},{"key":"1221_CR36","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/(SICI)1099-1611(199807\/08)7:4<291::AID-PON361>3.0.CO;2-U","volume":"7","author":"Holland","year":"1998","unstructured":"Holland JC, Romano SJ, Heiligenstein JH et al (1998) A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psychooncology 7:291\u2013300","journal-title":"Psychooncology"},{"key":"1221_CR37","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4081\/monaldi.2004.692","volume":"61","author":"Lacasse","year":"2004","unstructured":"Lacasse Y, Beaudoin L, Rousseau L, Maltais F (2004) Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis 61:140\u2013147","journal-title":"Monaldi Arch Chest Dis"},{"key":"1221_CR38","first-page":"199","volume":"10","author":"Mauri","year":"1994","unstructured":"Mauri MC, Ferrara A, Lorenza F et al (1994) A double blind study on fluvoxamine vs. placebo in depressed hiv positive patients: short-term and perspective results. Integr Psychiatry 10:199\u2013201","journal-title":"Integr Psychiatry"},{"key":"1221_CR39","first-page":"195","volume":"122","author":"Moeslinger-Gehmayr","year":"2000","unstructured":"Moeslinger-Gehmayr R, Zaninelli R, Contu A et al (2000) A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression. Zentralbl Gynakol 122:195\u2013202","journal-title":"Zentralbl Gynakol"},{"key":"1221_CR40","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4088\/JCP.v67n0217","volume":"67","author":"Musselman","year":"2006","unstructured":"Musselman DL, Somerset WI, Guo Y et al (2006) A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression. J Clin Psychiatry 67:288\u2013296","journal-title":"J Clin Psychiatry"},{"key":"1221_CR41","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2010.03.068","volume":"56","author":"O","year":"2010","unstructured":"O\u2019Connor CM, Jiang W, Kuchibhatla M et al (2010) Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 56:692\u2013699","journal-title":"J Am Coll Cardiol"},{"key":"1221_CR42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1176\/ajp.156.1.101","volume":"156","author":"Rabkin","year":"1999","unstructured":"Rabkin JG, Wagner GJ, Rabkin R (1999) Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial. Am J Psychiatry 156:101\u2013107","journal-title":"Am J Psychiatry"},{"key":"1221_CR43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/01.jcp.0000132442.35478.3c","volume":"24","author":"Rabkin","year":"2004","unstructured":"Rabkin JG, Wagner GJ, McElhiney MC et al (2004) Testosterone versus fluoxetine for depression and fatigue in HIV\/AIDS: a placebo-controlled trial. J Clin Psychopharmacol 24:379\u2013385","journal-title":"J Clin Psychopharmacol"},{"key":"1221_CR44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-0447.1996.tb09850.x","volume":"94","author":"Razavi","year":"1996","unstructured":"Razavi D, Allilaire JF, Smith M et al (1996) The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatr Scand 94:205\u2013210","journal-title":"Acta Psychiatr Scand"},{"key":"1221_CR45","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/(SICI)1520-6394(1999)9:2<70::AID-DA4>3.0.CO;2-L","volume":"9","author":"Schwartz","year":"1999","unstructured":"Schwartz JA, McDaniel JS (1999) Double-blind comparison of fluoxetine and desipramine in the treatment of depressed women with advanced HIV disease: a pilot study. Depress Anxiety 9:70\u201374","journal-title":"Depress Anxiety"},{"key":"1221_CR46","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S1470-2045(07)70148-1","volume":"8","author":"Stockler","year":"2007","unstructured":"Stockler MR, O\u2019Connell R, Nowak AK et al (2007) Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Lancet Oncol 8:603\u2013612","journal-title":"Lancet Oncol"},{"key":"1221_CR47","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0033-3182(94)71786-2","volume":"35","author":"Targ","year":"1994","unstructured":"Targ EF, Karasic DH, Diefenbach PN et al (1994) Structured group therapy and fluoxetine to treat depression in HIV-positive persons. Psychosomatics 35:132\u2013137","journal-title":"Psychosomatics"},{"key":"1221_CR48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4088\/JCP.v59n0502","volume":"59","author":"Zisook","year":"1998","unstructured":"Zisook S, Peterkin J, Goggin KJ et al (1998) Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group. J Clin Psychiatry 59:217\u2013224","journal-title":"J Clin Psychiatry"},{"key":"1221_CR49","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/030006059902700602","volume":"27","author":"Razavi","year":"1999","unstructured":"Razavi D, Kormoss N, Collard A et al (1999) Comparative study of the efficacy and safety of trazodone versus clorazepate in the treatment of adjustment disorders in cancer patients: a pilot study. J Int Med Res 27:264\u2013272","journal-title":"J Int Med Res"},{"key":"1221_CR50","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1200\/JCO.2004.99.206","volume":"22","author":"Alliot","year":"2004","unstructured":"Alliot C (2004) Fluoxetine versus placebo in advanced cancer outpatients. J Clin Oncol 22:204\u2013205","journal-title":"J Clin Oncol"},{"key":"1221_CR51","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1200\/JCO.2004.99.221","volume":"22","author":"Coyne","year":"2004","unstructured":"Coyne JC, Palmer SC, Shapiro PJ (2004) Prescribing antidepressants to advanced cancer patients with mild depressive symptoms is not justified. J Clin Oncol 22:205\u2013206","journal-title":"J Clin Oncol"},{"key":"1221_CR52","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1200\/JCO.2004.99.253","volume":"22","author":"Erwin","year":"2004","unstructured":"Erwin BA, Sullivan PA, Ten Have TR (2004) Trial of antidepressants for mildly depressed cancer patients should have been reported in a manner allowing independent evaluation of investigators\u2018 claims. J Clin Oncol 22:753\u2013754","journal-title":"J Clin Oncol"},{"key":"1221_CR53","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-0404.1980.tb03028.x","volume":"62","author":"Andersen","year":"1980","unstructured":"Andersen J, Aabro E, Gulmann N et al (1980) Anti-depressive treatment in Parkinson\u2019s disease. A controlled trial of the effect of nortriptyline in patients with Parkinson\u2019s disease treated with L-DOPA. Acta Neurol Scand 62:210\u2013219","journal-title":"Acta Neurol Scand"},{"key":"1221_CR54","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1176\/jnp.8.3.270","volume":"8","author":"Petracca","year":"1996","unstructured":"Petracca G, Teson A, Chemerinski E et al (1996) A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer\u2019s disease. J Neuropsychiatry Clin Neurosci 8:270\u2013275","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1221_CR55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1176\/ajp.146.1.45","volume":"146","author":"Reifler","year":"1989","unstructured":"Reifler BV, Teri L, Raskind M et al (1989) Double-blind trial of imipramine in Alzheimer\u2019s disease patients with and without depression. Am J Psychiatry 146:45\u201349","journal-title":"Am J Psychiatry"},{"key":"1221_CR56","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1176\/ajp.147.11.1562","volume":"147","author":"Schiffer","year":"1990","unstructured":"Schiffer RB, Wineman NM (1990) Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry 147:1493\u20131497","journal-title":"Am J Psychiatry"},{"key":"1221_CR57","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0033-3182(92)71995-1","volume":"33","author":"Borson","year":"1992","unstructured":"Borson S, McDonald GJ, Gayle T et al (1992) Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics 33:190\u2013201","journal-title":"Psychosomatics"},{"key":"1221_CR58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1600-0447.1985.tb08081.x","volume":"320","author":"Costa","year":"1985","unstructured":"Costa D, Mogos I, Toma T (1985) Efficacy and safety of mianserin in the treatment of depression of women with cancer. Acta Psychiatr Scand Suppl 320:85\u201392","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"1221_CR59","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2190\/16FH-9ECT-Y280-VV45","volume":"25","author":"Fernandez","year":"1995","unstructured":"Fernandez F, Levy JK, Samley HR et al (1995) Effects of methylphenidate in HIV-related depression: a comparative trial with desipramine. Int J Psychiatry Med 25:53\u201367","journal-title":"Int J Psychiatry Med"},{"key":"1221_CR60","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archinte.1986.00360190155022","volume":"146","author":"Light","year":"1986","unstructured":"Light RW, Merrill EJ, Despars J et al (1986) Doxepin treatment of depressed patients with chronic obstructive pulmonary disease. Arch Intern Med 146:1377\u20131380","journal-title":"Arch Intern Med"},{"key":"1221_CR61","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/archpsyc.55.5.452","volume":"55","author":"Markowitz","year":"1998","unstructured":"Markowitz JC, Kocsis JH, Fishman B et al (1998) Treatment of depressive symptoms in human immunodeficiency virus-positive patients. Arch Gen Psychiatry 55:452\u2013457","journal-title":"Arch Gen Psychiatry"},{"key":"1221_CR62","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1176\/ajp.151.4.516","volume":"151","author":"Rabkin","year":"1994","unstructured":"Rabkin JG, Rabkin R, Harrison W, Wagner G (1994) Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness. Am J Psychiatry 151:516\u2013523","journal-title":"Am J Psychiatry"},{"key":"1221_CR63","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1192\/bjp.169.4.440","volume":"169","author":"Heeringen","year":"1996","unstructured":"Heeringen K van, Zivkov M (1996) Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin. Br J Psychiatry 169:440\u2013443","journal-title":"Br J Psychiatry"},{"key":"1221_CR64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-0327(99)00092-0","volume":"58","author":"Anderson","year":"2000","unstructured":"Anderson IM (2000) Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 58:19\u201336","journal-title":"J Affect Disord"},{"key":"1221_CR65","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(10)70106-X","volume":"9","author":"Barone","year":"2010","unstructured":"Barone P, Poewe W, Albrecht S et al (2010) Pramipexole for the treatment of depressive symptoms in patients with Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 9:573\u2013580","journal-title":"Lancet Neurol"},{"key":"1221_CR66","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/bmj.326.7400.1171","volume":"326","author":"Melander","year":"2003","unstructured":"Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B (2003) Evidence b(i)ased medicine\u2014selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ 326:1171\u20131173","journal-title":"BMJ"},{"key":"1221_CR67","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMsa065779","volume":"358","author":"Turner","year":"2008","unstructured":"Turner EH, Matthews AM, Linardatos E et al (2008) Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 358:252\u2013260","journal-title":"N Engl J Med"},{"key":"1221_CR68","doi-asserted-by":"crossref","first-page":"772","DOI":"10.7326\/0003-4819-155-11-201112060-00009","volume":"155","author":"Gartlehner","year":"2011","unstructured":"Gartlehner G, Hansen RA, Morgan LC et al (2011) Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med 155:772\u2013785","journal-title":"Ann Intern Med"},{"key":"1221_CR69","unstructured":"Breitbart W, Dickerman A, Emanuel EJ et al (Hrsg) (2011) End of life care: Assessment and management of depression: http:\/\/www.uptodate.com. UpToDate\u00ae; Zugegriffen: 14.04.2011"},{"key":"1221_CR70","unstructured":"Keller M (2007) Depression. In: Aulbert E, Nauck F, Radbruch L (Hrsg) Lehrbuch der Palliativmedizin, 2. Aufl. Schattauer, Stuttgart, S\u00a01109\u20131127"},{"key":"1221_CR71","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/pon.1213","volume":"17","author":"Okamura","year":"2008","unstructured":"Okamura M, Akizuki N, Nakano T et al (2008) Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer. Psychooncology 17:154\u2013160","journal-title":"Psychooncology"},{"key":"1221_CR72","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1370\/afm.349","volume":"3","author":"Arroll","year":"2005","unstructured":"Arroll B, Macgillivray S, Ogston S et al (2005) Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Ann Fam Med 3:449\u2013456","journal-title":"Ann Fam Med"},{"key":"1221_CR73","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/bmj.306.6879.683","volume":"306","author":"Song","year":"1993","unstructured":"Song F, Freemantle N, Sheldon TA et al (1993) Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ 306:683\u2013687","journal-title":"BMJ"},{"key":"1221_CR74","unstructured":"(o A) (2009) Depression. In: Arzneiverordnungen, 22. Aufl. Deutscher \u00c4rzte-Verlag, K\u00f6ln, S\u00a0408\u2013437"},{"key":"1221_CR75","unstructured":"Arzneimittelkommission der deutschen \u00c4rzteschaft: Empfehlungen zur Therapie bei Depression, 2. Aufl. Arzneiverordnung in der Praxis (Therapieempfehlungen), Juli 2006; Bd\u00a033, Sonderheft 1"},{"key":"1221_CR76","first-page":"543","volume":"107","author":"Holt","year":"2010","unstructured":"Holt S, Schmiedl S, Thurmann PA (2010) Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 107:543\u2013551","journal-title":"Dtsch Arztebl Int"},{"key":"1221_CR77","first-page":"89","volume":"45","author":"AMB","year":"2011","unstructured":"AMB (2011) Behandlung \u00e4lterer Patienten mit Antidepressiva \u2013 eine kritischere Beurteilung ist notwendig. Arzneimittelbrief 45:89\u201391","journal-title":"Arzneimittelbrief"},{"key":"1221_CR78","doi-asserted-by":"crossref","first-page":"d4551","DOI":"10.1136\/bmj.d4551","volume":"343","author":"Coupland","year":"2011","unstructured":"Coupland C, Dhiman P, Morriss R et al (2011) Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 343:d4551","journal-title":"BMJ"},{"key":"1221_CR79","doi-asserted-by":"crossref","unstructured":"Lohse MJ, Mueller-Oerlinghausen B (2011) Psychopharmaka. In: Schwabe U, Paffrath D (Hrsg) Arzneiverordnungs-Report 2011. Springer Medizin, Berlin, S\u00a0813\u2013858","DOI":"10.1007\/978-3-642-21992-4_39"},{"key":"1221_CR80","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-0029-1245535","volume":"78","author":"Storch","year":"2010","unstructured":"Storch A, Schneider C, Ebersbach G et al (2010) Depression beim idiopathischen Parkinson-Syndrom, Teil 2: Therapie und Management. Fortschr Neurol Psychiatr 78:456\u2013467","journal-title":"Fortschr Neurol Psychiatr"},{"key":"1221_CR81","unstructured":"Lundbeck GmbH: Zusammenhang von Escitalopram (Cipralex\u00ae) mit dosisabh\u00e4ngiger QT-Intervall-Verl\u00e4ngerung: http:\/\/www.akdae.de\/Arzneimittelsicherheit\/RHB\/Archiv\/2011\/20111205.pdf. Rote-Hand-Brief vom 05.12.2011. Zugegriffen: 15.12.2011"},{"key":"1221_CR82","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1055\/s-0030-1263167","volume":"43","author":"Wenzel-Seifert","year":"2010","unstructured":"Wenzel-Seifert K, Wittmann M, Haen E (2010) Torsade de Pointes episodes under treatment with selective serotonin reuptake inhibitors. Pharmacopsychiatry 43:279\u2013281","journal-title":"Pharmacopsychiatry"},{"key":"1221_CR83","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1371\/journal.pmed.0050045","volume":"5","author":"Kirsch","year":"2008","unstructured":"Kirsch I, Deacon BJ, Huedo-Medina TB et al (2008) Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 5:e45","journal-title":"PLoS Med"},{"key":"1221_CR84","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1055\/s-2004-826874","volume":"129","author":"M\u00fcller-Oerlinghausen","year":"2004","unstructured":"M\u00fcller-Oerlinghausen B, Berg C, Scherer P et al (2004) Effects of slow-stroke massage as complementary treatment of depressed hospitalized patients. Dtsch Med Wochenschr 129:1363\u20131368","journal-title":"Dtsch Med Wochenschr"},{"key":"1221_CR85","doi-asserted-by":"crossref","unstructured":"Saarto T, Wiffen PJ (2007) Antidepressants for neuropathic pain. Cochrane Database Syst Rev CD005454","DOI":"10.1002\/14651858.CD005454.pub2"},{"key":"1221_CR86","doi-asserted-by":"crossref","unstructured":"Furukawa T, McGuire H, Barbui C (2003) Low dosage tricyclic antidepressants for depression. Cochrane Database Syst Rev D003197","DOI":"10.1002\/14651858.CD003197"},{"key":"1221_CR87","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jacc.2010.03.067","volume":"56","author":"Goodlin","year":"2010","unstructured":"Goodlin SJ (2010) Sadness in heart failure: what is a clinician to do? J Am Coll Cardiol 56:700\u2013701","journal-title":"J Am Coll Cardiol"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-012-1221-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00482-012-1221-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-012-1221-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T07:02:38Z","timestamp":1744095758000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00482-012-1221-x"}},"subtitle":["Eine systematische Literatur\u00fcbersicht","A systematic literature review"],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":87,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["1221"],"URL":"https:\/\/doi.org\/10.1007\/s00482-012-1221-x","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"type":"print","value":"0932-433X"},{"type":"electronic","value":"1432-2129"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}